Literature DB >> 10602562

Dependence of Human Vascular Cell Surface Proteolysis on Expression of the Urokinase Receptor.

.   

Abstract

To delineate the role of binding of urokinase type plasminogen activator (uPA) to its receptor (uPAR) in the local generation of plasmin by endothelium, we transfected spontaneously transformed immortalized human vascular endothelial cells that express high levels of uPA but low levels of uPAR with human uPAR complementary DNA. Compared with nontransfected cell, the stably transformed clonal cell line exhibited (a) a >10-fold increase in steady-state uPAR mRNA levels documented with Northern blot analysis (n = 3), (b) a 2.8-fold increase in cell surface expression of uPAR protein quantified by enzyme linked immunosorbent assay (n = 3), (c) a 2.9-fold increase in specific binding of radiolabeled single chain uPA (n = 4), and (d) markedly increased matrix adhesion. The participation of uPAR in cell surface proteolysis was apparent based on a 3.0-fold increase in cell associated plasmin activity (n = 3) and a 2.3-fold increase in lysis of noncrosslinked fibrin clots (n = 5). Thus, local generation of plasmin and consequent degradation of fibrin are likely to be promoted by cell surface localization of uPA by uPAR in cellular constituents of the vessel wall. Furthermore, genetic engineering of endothelium to enhance expression of uPAR may confer resistance to thrombosis or restenosis associated with endovascular stents.

Entities:  

Year:  1996        PMID: 10602562     DOI: 10.1007/BF00133076

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  21 in total

Review 1.  Plasminogen activation by receptor-bound urokinase.

Authors:  V Ellis; K Danø
Journal:  Semin Thromb Hemost       Date:  1991-07       Impact factor: 4.180

2.  Human endothelial cell line, ECV304, produces pro-urokinase.

Authors:  K Takahashi; Y Sawasaki
Journal:  In Vitro Cell Dev Biol       Date:  1991-10

3.  Identification of the urokinase receptor as an adhesion receptor for vitronectin.

Authors:  Y Wei; D A Waltz; N Rao; R J Drummond; S Rosenberg; H A Chapman
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

4.  Angiographic and clinical outcome of intracoronary stenting: immediate and long-term results from a large single-center experience.

Authors:  J P Carrozza; R E Kuntz; M J Levine; R M Pomerantz; R F Fishman; M Mansour; C M Gibson; C C Senerchia; D J Diver; R D Safian
Journal:  J Am Coll Cardiol       Date:  1992-08       Impact factor: 24.094

5.  Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.

Authors:  E S Barnathan; A Kuo; L Rosenfeld; K Karikó; M Leski; F Robbiati; M L Nolli; J Henkin; D B Cines
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

6.  Inhibition of type-1 plasminogen activator inhibitor production by antisense oligonucleotides in human vascular endothelial and smooth muscle cells.

Authors:  H Sawa; B E Sobel; S Fujii
Journal:  J Biol Chem       Date:  1994-05-13       Impact factor: 5.157

7.  Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.

Authors:  C H Lundgren; H Sawa; B E Sobel; S Fujii
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

8.  Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor.

Authors:  V Ellis; N Behrendt; K Danø
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

9.  Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells.

Authors:  X N Li; V K Varma; J M Parks; R L Benza; J C Koons; J R Grammer; H Grenett; E M Tabengwa; F M Booyse
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-03       Impact factor: 8.311

10.  In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.

Authors:  L Ossowski; G Clunie; M T Masucci; F Blasi
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.